Live feed
Filing
SC 13G
SC 13G0001193125-21-109044·Ikarian Capital, LLC
Schedule 13G ownership disclosure
Millendo Therapeutics, Inc.
Security class unavailable · CUSIP: 60040X103
Event date: 2021-03-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-109044
- Form type
- SC 13G
- Filer
- Ikarian Capital, LLC
- CIK
- CIK 1778253
- Filed
- Apr 07, 2021
- Reporting period
- Mar 18, 2021
- Description
- Schedule 13G beneficial ownership